Business Description
Bioelectronics Corp
NAICS : 333248
SIC : 3845
ISIN : US09062H1086
Description
Bioelectronics Corp is a US-based electroceutical company that develops wearable neuromodulation devices using pulsed electromagnetic field technology to relieve pain and support tissue recovery without drugs. Its product line includes ActiPatch for musculoskeletal pain, Allay for menstrual pain, RecoveryRx for postoperative and chronic wounds, and a smart insole for heel pain. The company sells through wholesale distributors, directly to hospitals and clinics, and to consumers, generating revenue from device sales across these channels. Its technology targets neurological and pain-related conditions, with a focus on non-invasive, drug-free treatment alternatives.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.63 | |||||
9-Day RSI | 34.07 | |||||
14-Day RSI | 38.35 | |||||
3-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | 91.51 | |||||
EV-to-EBITDA | 91.51 | |||||
EV-to-Revenue | 14.5 | |||||
EV-to-FCF | -49.09 | |||||
Earnings Yield (Greenblatt) % | 1.09 | |||||
FCF Yield % | -2.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Bioelectronics Corp Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.511 | ||
| EPS (TTM) ($) | - | ||
| Beta | 2.8707 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 1.82 | ||
| Volatility % | 247.8 | ||
| 14-Day RSI | 38.35 | ||
| 14-Day ATR ($) | 0.000102 | ||
| 20-Day SMA ($) | 0.00033 | ||
| 12-1 Month Momentum % | 50 | ||
| 52-Week Range ($) | 0.0001 - 0.0014 | ||
| Shares Outstanding (Mil) | 24,705.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioelectronics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioelectronics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 52 days | ||
| General meeting for 2025 | 2026-09-15 | 0.00 (+33.33%) | ||
| Second quarter earnings results for 2026 | 2026-09-11 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-15 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-05-01 | 0.00 (+0.00%) |
Show
Entries
Bioelectronics Corp Frequently Asked Questions
What is Bioelectronics Corp(BIEL)'s stock price today?
The current price of BIEL is $0.00. The 52 week high of BIEL is $0.00 and 52 week low is $0.00.
When is next earnings date of Bioelectronics Corp(BIEL)?
The next earnings date of Bioelectronics Corp(BIEL) is 2026-11-13 Est..
Does Bioelectronics Corp(BIEL) pay dividends? If so, how much?
Bioelectronics Corp(BIEL) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers